{
  "$schema": "folio-library-entry/v1",
  "id": "9789241549912-eng",
  "blocks": [
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 7,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care \nfor a positive pregnancy experience\nWHO Library Cataloguing-in-Publication Data\nWHO recommendations on antenatal care for a positive pregnancy experience.\nI.World Health Organization.\nISBN 978 92 4 154991 2\nSubject headings are available from WHO institutional repository\n© World Health Organization 2016\nAll rights reserved. Publications of the World Health Organization are available on the WHO website \n(http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, \n1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; f",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Front matter for the 2016 WHO publication 'WHO recommendations on antenatal care for a positive pregnancy experience' (ISBN 978-92-4-154991-2). Includes the title page, WHO Library Cataloguing-in-Publication data, copyright and legal disclaimers, a full table of contents spanning Chapters 1–6 and Annexes 1–4, links to the accompanying web annexes and evidence supplement, and an opening endorsement quote from UN Secretary-General Ban Ki-moon on implementing the Every Woman Every Child Global Strategy.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Acknowledgements",
      "pageStart": 7,
      "pageEnd": 9,
      "target": "../sections/sec-000-acknowledgements.md",
      "narrative": null,
      "content": "Acknowledgements\nThe Departments of Reproductive Health and Research (RHR), Nutrition for Health and Development (NHD), \nand Maternal, Newborn, Child and Adolescent Health (MCA) of the World Health Organization (WHO) \ngratefully acknowledge the contributions that many individuals and organizations have made to the development \nof this guideline.\nA. Metin Gülmezoglu, Matthews Mathai, Olufemi Oladapo, Juan Pablo Peña-Rosas and Özge Tunçalp were the \nmembers of the WHO Steering Group that managed the guideline development process. The members of the \nGuideline Development Group (GDG) included Moh",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Acknowledgements recognizing the contributors to the 2016 WHO antenatal care guideline, coordinated by the WHO Departments of Reproductive Health and Research (RHR), Nutrition for Health and Development (NHD), and Maternal, Newborn, Child and Adolescent Health (MCA). Names the WHO Steering Group, the Guideline Development Group (GDG) chaired by James Neilson, regional advisors, systematic review and grading teams (Cochrane Pregnancy and Childbirth Group led by Theresa Lawrie, qualitative review teams at UCLan and Norwegian Institute of Public Health, and diagnostic test accuracy reviewers at Queen Mary University of London), DECIDE and FANC country case-study methodologists, observer organizations (FIGO, ICM, IPA, Jhpiego, PMNCH, UNFPA, USAID), external peer reviewers, and financial support from USAID, the Bill & Melinda Gates Foundation, and HRP.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Acronyms and abbreviations",
      "pageStart": 9,
      "pageEnd": 11,
      "target": "../sections/sec-001-acronyms-and-abbreviations.md",
      "narrative": null,
      "content": "Acronyms and abbreviations\nANC\t\n\tantenatal care\nASB\t\n\tasymptomatic bacteriuria\nBMI\t\n\tbody mass index\nCERQual\t\nConfidence in the Evidence from Reviews of Qualitative Research\nCI\t\n\tconfidence interval\nCTG\t\n\tcardiotocography\nDECIDE\t\n\tDeveloping and Evaluating Communication strategies to support Informed Decisions \n\tand Practice based on Evidence\nDOI\t\n\tdeclaration of interest\nEB\t\n\tevidence base\nEGWG\t\n\texcessive gestational weight gain\nERG\t\n\tExternal Review Group\nFANC\t\n\tfocused antenatal care\nFIGO\t\n\tInternational Federation of Gynecology and Obstetrics\nGBS\t\n\tgroup B streptococcus\nGDG\t\n\tGuideline De",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Glossary of acronyms and abbreviations used throughout the 2016 WHO antenatal care guideline, ranging from clinical and diagnostic terms (ANC, ASB, BMI, BPP, CFU, CTG, DTA, ECV, FANC, FBC, FHR, GDM, GWG, HELLP, IPTp-SP, IPV, IUGR, LBW, MLCC, MMN, OGTT, PITC, PrEP, PROM, PTB, RUTI, SFH, SGA, STI, TB, TT, UTI) to methodological and institutional abbreviations (CERQual, CI, CREP, DECIDE,ERG, EtD, FIGO, GDG, GRADE, GRC, HRP, ICM, LMIC, MCA, NHD, OptimizeMNH, PICO, PLA, RHR, UNIMMAP, USAID, WHO).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Executive summary",
      "pageStart": 11,
      "pageEnd": 19,
      "target": "../sections/sec-002-executive-summary.md",
      "narrative": null,
      "content": "Executive summary\nIntroduction\nIn 2016, at the start of the Sustainable Development Goals (SDGs) era, pregnancy-related preventable morbidity \nand mortality remains unacceptably high. While substantial progress has been made, countries need to \nconsolidate and increase these advances, and to expand their agendas to go beyond survival, with a view to \nmaximizing the health and potential of their populations.\nThe World Health Organization (WHO) envisions a world where every pregnant woman and newborn receives \nquality care throughout the pregnancy, childbirth and the postnatal period. Within the",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Executive summary of the 2016 WHO antenatal care (ANC) guideline. Defines a 'positive pregnancy experience' around four pillars (maintaining physical and sociocultural normality, maintaining a healthy pregnancy for mother and baby, effective transition to positive labour and birth, and achieving positive motherhood), outlines the GRADE, GRADE-CERQual, and DECIDE Evidence-to-Decision (EtD) methods used across three GDG technical consultations in 2015–2016, explains the shift from the 4-visit focused ANC (FANC) model to a minimum of eight ANC contacts, and presents Table 1 summarizing all 49 recommendations (39 newly formulated by the GDG and 10 integrated from existing WHO guidelines) across five intervention categories: A. Nutritional interventions, B. Maternal and fetal assessment, C. Preventive measures, D. Interventions for common physiological symptoms, and E. Health systems interventions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 19,
      "pageEnd": 22,
      "target": "../sections/sec-003-1-introduction.md",
      "narrative": null,
      "content": "Chapter 1. Introduction\n1. Introduction\n1.1 Background\nInternational human rights law includes fundamental \ncommitments of states to enable women and \nadolescent girls to survive pregnancy and childbirth \nas part of their enjoyment of sexual and reproductive \nhealth and rights and living a life of dignity (1). The \nWorld Health Organization (WHO) envisions a world \nwhere “every pregnant woman and newborn receives \nquality care throughout the pregnancy, childbirth and \nthe postnatal period” (2). However, approximately \n303 000 women and adolescent girls died as a result \nof pregnancy and childb",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 1 (Introduction) establishing the background, rationale, target audience, and scope of the 2016 WHO ANC guideline. Reviews global maternal mortality (303,000 deaths in 2015) and stillbirth burdens (2.6 million in 2015), explains why the 2002 4-visit FANC model proved insufficient and how vertical disease programmes fragmented routine ANC, situates the guideline within the SDGs and Every Woman Every Child Global Strategy, defines the person-centred and human-rights-based concept of a positive pregnancy experience, specifies the adolescent and adult pregnant population and health-system audience, and lists the priority maternal, fetal/neonatal, test-accuracy, and health-system outcomes in Box 1.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Methods",
      "pageStart": 22,
      "pageEnd": 31,
      "target": "../sections/sec-004-2-methods.md",
      "narrative": null,
      "content": "2. Methods\nThe guideline was developed in accordance with \nthe methods described in the WHO handbook for \nguideline development (14). In summary, the process \nincluded: identification of priority questions and \noutcomes, retrieval of evidence, assessment \nand synthesis of the evidence, formulation \nof recommendations, and planning for the \nimplementation, dissemination, impact evaluation \nand updating of the guideline.\n2.1 WHO Steering Group\nThe WHO Steering Group that guided the entire \nguideline development process comprised WHO \nstaff members from the Department of Reproductive \nHealth and",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 2 (Methods) detailing the governance and methodological processes used to develop the 2016 WHO ANC guideline in accordance with the 2014 WHO handbook for guideline development. Describes the composition and roles of the WHO Steering Group (RHR, MCA, NHD, plus HIV, Malaria, TB, and Mental Health/Substance Abuse units), the 20-member Guideline Development Group (GDG), the 6-member External Review Group (ERG), and the Technical Working Group (TWG); the 2014 scoping exercise and PICO prioritization; cross-checking and integration of 21 GRC-approved WHO guidelines; the five evidence work streams summarized in Box 2 (quantitative intervention and DTA reviews, qualitative syntheses on women's and providers' views, and FANC country case studies in Argentina, Kenya, Thailand, and the United Republic of Tanzania); quality assessment via GRADE and GRADE-CERQual; the DECIDE Evidence-to-Decision (EtD) framework across effects, values, resources, equity, acceptability, and feasibility; recommendation classification ('Recommended', 'Not recommended', and 'Context-specific recommendation' in research or specific contexts); consensus decision-making; declaration of interest management; and document peer review.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Evidence and recommendations",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/sec-005-3-evidence-and-recommendations.md",
      "narrative": null,
      "content": "13\n3. Evidence and recommendations\nThis ANC guideline includes 39 recommendations \nadopted by the Guideline Development Group \n(GDG), and 10 recommendations relevant to ANC \nthat have been consolidated into this guideline \nfrom other existing WHO guidelines that have \nbeen recently approved by the Guidelines Review \nCommittee (GRC). Evidence on the effectiveness of \ninterventions was derived from 47 systematic reviews \n(41 Cochrane systematic reviews, 2 test accuracy \nreviews and 4 non-Cochrane reviews of non-\nrandomized studies) and was summarized in GRADE \ntables. A scoping review of what wo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Opening of Chapter 3 (Evidence and recommendations), introducing the structure of the guideline's 39 GDG-adopted recommendations and 10 integrated WHO recommendations across five topical sections (A–E), supported by 47 systematic reviews (41 Cochrane intervention reviews, 2 diagnostic test accuracy reviews, and 4 non-randomized study reviews), qualitative syntheses, FANC implementation case studies, and external Web Annexes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "A. Nutritional interventions",
      "pageStart": 31,
      "pageEnd": 58,
      "target": "../sections/sec-006-a-nutritional-interventions.md",
      "narrative": null,
      "content": "B.\tMaternal and fetal assessment\nC.\tPreventive measures\nD.\tInterventions for common physiological \nsymptoms\nE.\tHealth systems interventions to improve the \nutilization and quality of ANC.\nThe corresponding GRADE tables for \nrecommendations are referred to in this chapter as \n“evidence base” (EB) tables, numbered according \nto the specific recommendations they refer to. \nThese tables are presented separately in the \nWeb supplement to this document.3 Evidence-to-\ndecision tables with GDG judgements related to \nthe evidence and considerations for all domains \nare presented in Web annex 3 of this",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 3, Section A (Nutritional interventions), presenting background epidemiology on maternal malnutrition, overweight/obesity, and anaemia alongside evidence summaries, DECIDE EtD considerations (values, resources, equity, acceptability, feasibility), and implementation remarks for 14 nutritional recommendations: A.1.1 counselling on healthy eating and physical activity (recommended), A.1.2 nutrition education on increasing daily energy and protein intake in undernourished populations (context-specific), A.1.3 balanced energy and protein dietary supplementation in undernourished populations (context-specific), A.1.4 high-protein supplementation (not recommended), A.2.1 daily oral iron (30–60 mg) and folic acid (400 µg) supplementation (recommended), A.2.2 intermittent oral iron (120 mg) and folic acid (2800 µg) weekly where daily iron is unacceptable or anaemia prevalence is <20% (context-specific), A.3 daily calcium supplementation (1.5–2.0 g) in low-calcium-intake populations (context-specific), A.4 vitamin A supplementation where vitamin A deficiency is a severe public health problem (context-specific), A.5 zinc supplementation (context-specific research), A.6 multiple micronutrient supplements (not recommended), A.7 vitamin B6 supplements (not recommended), A.8 vitamin E and C supplements (not recommended), A.9 vitamin D supplements (not recommended), and A.10 lowering daily caffeine intake for women consuming >300 mg/day (context-specific).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "B. Maternal and fetal assessment",
      "pageStart": 58,
      "pageEnd": 81,
      "target": "../sections/sec-007-b-maternal-and-fetal-assessment.md",
      "narrative": null,
      "content": "B. Maternal and fetal assessment\nB.1: Maternal assessment\nBackground\nHypertensive disorders of pregnancy are important \ncauses of maternal and perinatal morbidity and \nmortality, with approximately a quarter of maternal \ndeaths and near misses estimated to be due to pre-\neclampsia and eclampsia (9). Antenatal screening \nfor pre-eclampsia is an essential part of good ANC. \nIt is routinely performed by measuring maternal \nblood pressure and checking for proteinuria at each \nANC contact and, upon detection of pre-eclampsia, \nspecific management is required to prevent eclampsia \nand other poor mat",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 3, Section B (Maternal and fetal assessment), covering evidence syntheses, EtD judgements, and clinical remarks for maternal assessments B.1.1–B.1.8 and fetal assessments B.2.1–B.2.5. Maternal assessments include B.1.1 full blood count testing or on-site haemoglobinometer over haemoglobin colour scale for diagnosing anaemia in pregnancy (context-specific), B.1.2 midstream urine culture or on-site Gram stain over dipstick tests for diagnosing asymptomatic bacteriuria (context-specific), B.1.3 clinical enquiry about intimate partner violence (IPV) at ANC visits when minimum support and referral requirements are met (context-specific, with Box 3 listing IPV signs/conditions), B.1.4 diagnostic criteria and 75 g OGTT thresholds for hyperglycaemia/gestational diabetes mellitus (GDM) in pregnancy (recommended, integrated from 2013 WHO guideline), B.1.5 routine enquiry on tobacco use and second-hand smoke exposure at every ANC visit (recommended, integrated), B.1.6 routine enquiry on alcohol and substance use at every ANC visit (recommended, integrated), B.1.7 provider-initiated HIV testing and counselling (PITC) in high-prevalence and low-prevalence settings integrated with syphilis and other key tests (recommended/context-specific, integrated), and B.1.8 systematic screening for active tuberculosis where TB prevalence is ≥100/100,000 (context-specific, integrated). Fetal assessments include B.2.1 daily fetal movement counting (context-specific research), B.2.2 symphysis-fundal height (SFH) measurement versus clinical abdominal palpation (context-specific), B.2.3 routine antenatal cardiotocography (not recommended), B.2.4 one early ultrasound scan before 24 weeks of gestation (recommended), and B.2.5 routine Doppler ultrasound of fetal blood vessels (not recommended).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "C. Preventive measures",
      "pageStart": 81,
      "pageEnd": 123,
      "target": "../sections/sec-008-c-preventive-measures.md",
      "narrative": null,
      "content": "C. Preventive measures\nBackground\nThe GDG considered the evidence and other relevant \ninformation to inform recommendations on antenatal \ninterventions to prevent the following conditions.\nn\nn Asymptomatic bacteriuria (ASB): Defined as true \nbacteriuria in the absence of specific symptoms \nof acute urinary tract infection, ASB is common \nin pregnancy, with rates as high as 74% reported \nin some LMICs (125). Escherichia coli is associated \nwith up to 80% of isolates (83). Other pathogens \ninclude Klebsiella species, Proteus mirabilis and \ngroup B streptococcus (GBS). While ASB in non-\npregnant",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 3, Sections C (Preventive measures), D (Interventions for common physiological symptoms), and E (Health systems interventions to improve utilization and quality of ANC), plus the opening of Chapter 4. Section C covers C.1 a 7-day antibiotic regimen for asymptomatic bacteriuria (recommended), C.2 antibiotic prophylaxis for recurrent UTIs (context-specific research), C.3 antenatal anti-D immunoglobulin prophylaxis at 28 and 34 weeks in non-sensitized Rh-negative women (context-specific research), C.4 single-dose albendazole or mebendazole after the first trimester where hookworm/T. trichiura prevalence is ≥20% and anaemia is ≥40% (context-specific), C.5 tetanus toxoid vaccination (recommended), C.6 intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) starting in the second trimester at least one month apart for ≥3 doses in malaria-endemic areas in Africa (context-specific, integrated), and C.7 oral TDF-based pre-exposure prophylaxis (PrEP) for pregnant women at substantial HIV risk (context-specific, integrated). Section D covers D.1 ginger, chamomile, vitamin B6, and/or acupuncture for nausea in early pregnancy, D.2 diet/lifestyle advice and antacids for heartburn, D.3 magnesium, calcium, or non-pharmacological options for leg cramps, D.4 regular exercise plus physiotherapy, support belts, and acupuncture for low back and pelvic pain, D.5 wheat bran or fibre supplements for constipation, and D.6 compression stockings, leg elevation, and water immersion for varicose veins and oedema (all recommended based on women's preferences). Section E covers E.1 woman-held case notes (recommended), E.2 midwife-led continuity of care (MLCC) in settings with well-functioning midwifery programmes (context-specific), E.3 group ANC in research settings (context-specific research), E.4.1 facilitated participatory learning and action (PLA) cycles with women's groups and E.4.2 household/community mobilization with antenatal home visits in rural low-access settings (both context-specific), E.5.1–E.5.2 task shifting health promotion and nutritional/IPTp supplement distribution across health worker cadres (recommended, with Box 4 comparing OptimizeMNH and ANC recommendations), E.6 educational, regulatory, financial, and professional support interventions to recruit and retain rural staff (context-specific, integrated), and E.7 ANC models with a minimum of eight contacts to reduce perinatal mortality and improve women's experience of care (recommended).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Implementation of the ANC guideline and recommendations: introducing the 2016 WHO ANC model",
      "pageStart": 123,
      "pageEnd": 136,
      "target": "../sections/sec-009-4-implementation-of-the-anc-guideline-and-recomm.md",
      "narrative": null,
      "content": "Box 5: Comparing ANC schedules\nWHO FANC \nmodel\n2016 WHO ANC \nmodel\nFirst trimester\nVisit 1: 8–12 weeks\nContact 1: up to 12 weeks\nSecond trimester\nVisit 2: 24–26 weeks\nContact 2: 20 weeks\nContact 3: 26 weeks\nThird trimester\nVisit 3: 32 weeks\nVisit 4: 36–38 weeks\nContact 4: 30 weeks\nContact 5: 34 weeks\nContact 6: 36 weeks\nContact 7: 38 weeks\nContact 8: 40 weeks\nReturn for delivery at 41 weeks if not given birth.\nWHO recommendations on antenatal care for a positive pregnancy experience\n106\nindividualized, person-centred care at every \ncontact, with implementation of effective clinical \npractices",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 4 (Implementation of the ANC guideline and recommendations), detailing how to operationalize the 2016 WHO ANC model. Emphasizes shifting from 'visits' to 'contacts' that integrate clinical care, timely information, and psychosocial support; presents Box 5 comparing the 4-visit FANC schedule with the 2016 WHO 8-contact schedule (Contact 1 up to 12 weeks, Contact 2 at 20 weeks, Contact 3 at 26 weeks, Contact 4 at 30 weeks, Contact 5 at 34 weeks, Contact 6 at 36 weeks, Contact 7 at 38 weeks, and Contact 8 at 40 weeks, plus return at 41 weeks if undelivered); provides Table 2 mapping all recommended and context-specific interventions across the eight scheduled contacts with detailed clinical footnotes; and sets out Box 6 on health-policy, health-system/organizational, and user-level considerations for adopting and scaling up the 2016 WHO ANC model, followed by the start of Box 7's priority research questions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Research implications",
      "pageStart": 136,
      "pageEnd": 139,
      "target": "../sections/sec-010-5-research-implications.md",
      "narrative": null,
      "content": "During the guideline development process, the \nGuideline Development Group (GDG) identified \nimportant knowledge gaps that need to be addressed \nthrough primary research. The certainty of evidence \nwas rated as “low” or “very low” for a number of \ninterventions evaluated. According to GRADE \nmethodology (15), this implies that further research \non interventions with “low” or “very low” certainty \nevidence for important outcomes is likely to have \nan impact on future certainty and subsequent \nrecommendations related to these interventions. The \nGDG identified knowledge gaps based on this concep",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 5 (Research implications—continuation of Box 7) and Chapter 6, Section 6.1 (Guideline dissemination). Completes Box 7's priority research questions across Section B (on-site anaemia and ASB diagnostics, IPV enquiry, early ultrasound before 24 weeks in LMICs, and Doppler ultrasound), Section C (short vs 7-day ASB antibiotics, RUTI prophylaxis, anti-D immunoglobulin in LMICs, and malaria/HIV interactions), Section D (physiological symptoms), and Section E (electronic vs paper woman-held notes, MLCC scale-up, group ANC trials, community mobilization, and impact of the 8-contact schedule). Section 6.1 outlines dissemination in all six UN languages through WHO regional/country offices, the WHO Reproductive Health Library (RHL), evidence briefs co-produced with USAID, FIGO, and ICM, an interactive web-based guideline platform, HRP News, and the OptimizeMNH database.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Chapter 6. Dissemination, applicability and updating of the guideline and recommendations",
      "pageStart": 139,
      "pageEnd": 141,
      "target": "../sections/sec-011-chapter-6-dissemination-applicability-and-updati.md",
      "narrative": null,
      "content": "Chapter 6. Dissemination, applicability and updating\nthe Department of RHR.8 The ANC guideline \nrecommendations will be made available via this new \nsearch function.\nThe Maternal and Perinatal Health and Preventing \nUnsafe Abortion team of the WHO Department \nof RHR, in collaboration with the Departments of \nNHD and MCA and other partners, will support \nnational and subnational working groups to adapt \nand implement the guideline. This process will \ninclude the development or revision of existing \nnational guidelines or protocols in line with the WHO \nguideline. The GREAT Network (Guideline-dr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Chapter 6, Sections 6.1 (continuation on local adaptation via the GREAT Network), 6.2 (Applicability issues and monitoring and evaluation), and 6.3 (Updating the guideline). Discusses anticipated implementation barriers (human resources, training, referral systems, equipment, commodities, and health management information systems), recommends clinical audits and interrupted time-series analyses to monitor coverage and quality of the 8-contact ANC model, and describes WHO's 5-year living-guideline update strategy, a planned 2-year implementation survey, and upcoming guideline work on GDM, syphilis, and haemoglobinopathies.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 141,
      "pageEnd": 155,
      "target": "../sections/sec-012-references.md",
      "narrative": null,
      "content": "123\nReferences\n1.\t\nOffice of the United Nations High Commissioner \nfor Human Rights (OHCHR). Technical guidance \non the application of a human rights-based \napproach to the implementation of policies and \nprogrammes to reduce preventable maternal \nmorbidity and mortality. Human Rights \nCouncil, twentieth session. New York (NY): \nUnited Nations General Assembly; 2012 (A/\nHRC/21/22; http://www2.ohchr.org/english/\nissues/women/docs/A.HRC.21.22_en.pdf, \naccessed 28 September 2016).\n2.\t\nTunçalp Ö, Were WM, MacLennan C, Oladapo \nOT, Gülmezoglu AM, Bahl R et al. Quality of \ncare for pregnant women an",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Numbered bibliographic reference list (References 1–214) for the 2016 WHO antenatal care guideline, citing global maternal and perinatal epidemiology reports, WHO technical guidelines, GRADE and GRADE-CERQual methodology papers, qualitative evidence syntheses, and the Cochrane and diagnostic test accuracy systematic reviews underpinning the 49 recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Annex 1:\tExternal experts and WHO staff involved in the preparation of this guideline",
      "pageStart": 155,
      "pageEnd": 159,
      "target": "../sections/sec-013-annex-1-external-experts-and-who-staff-involved.md",
      "narrative": null,
      "content": "the preparation of this guideline\nWHO Steering Group (Geneva, Switzerland)\nA. Metin Gülmezoglu\nCoordinator\nDepartment of Reproductive Health and Research\nMaternal and Perinatal Health & Preventing Unsafe \nAbortion Team \nMatthews Mathai\nCoordinator\nDepartment of Maternal, Newborn, Child and \nAdolescent Health \nEpidemiology, Monitoring and Evaluation Team\nOlufemi T. Oladapo\nMedical Officer\nDepartment of Reproductive Health and Research\nMaternal and Perinatal Health & Preventing Unsafe \nAbortion Team\nJuan Pablo Peña-Rosas\nCoordinator\nDepartment Nutrition for Health and Development\nEvidence and Pr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 1 listing all external experts and WHO staff involved in preparing the 2016 WHO ANC guideline, including institutional affiliations and locations for the WHO Steering Group, the 20 Guideline Development Group (GDG) members, Observers, the Technical Working Group (systematic review teams and methodologists), WHO regional office advisors, WHO headquarters contributors, and the External Review Group.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Annex 2: Other WHO guidelines with recommendations relevant to routine ANC",
      "pageStart": 159,
      "pageEnd": 161,
      "target": "../sections/sec-014-annex-2-other-who-guidelines-with-recommendation.md",
      "narrative": null,
      "content": "WHO guideline title\nYear of \npublication\nWHO department responsible\nApproach\n1. \t Increasing access to health workers in remote and \nrural areas through improved retention: global policy \nrecommendations\n2010\nVarious WHO departments and regional \nrepresentatives.\nRecommendation relevant to ANC was adapted for, and \nintegrated into, the ANC guideline.\n2. \t Guideline: vitamin A supplementation in pregnant women\n2011\nDepartment of Nutrition for Health and \nDevelopment (NHD)\nDepartment of Reproductive Health and \nResearch (RHR)\nDepartment of Maternal, Newborn, Child and \nAdolescent Health (MCA)\nNe",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 2 presenting a summary table of 21 GRC-approved WHO guidelines (published 2010–2016) containing recommendations relevant to routine antenatal care, listing each guideline's title, year of publication, responsible WHO departments, and how its recommendations were handled in the 2016 ANC guideline (integrated directly, adapted, superseded by updated evidence, or cross-referenced).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Annex 3:\tSummary of declarations of interest from the Guideline Development Group (GDG) members and how they were managed",
      "pageStart": 161,
      "pageEnd": 163,
      "target": "../sections/sec-015-annex-3-summary-of-declarations-of-interest-from.md",
      "narrative": null,
      "content": "Annex 3: Summary of declarations of interest\nAnnex 3:\t Summary of declarations of interest from \nthe Guideline Development Group (GDG) \nmembers and how they were managed\nName\nExpertise\nDisclosure of interest\nConflict of interest and \nmanagement\nDr Ariful Alam\nNutrition, health systems\nNone declared\nNot applicable\nDr Françoise Cluzeau\nEvidence synthesis and guideline \ndevelopment using the Grading of \nRecommendations Assessment, \nDevelopment and Evaluation \n(GRADE) approach \nNone declared\nNot applicable\nDr Luz Maria De-Regil\nNutrition, epidemiology, \nsystematic reviews, programme \nimplementatio",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 3 summarizing the declarations of interest (DOI) for all 19 participating Guideline Development Group (GDG) members, listing each member's areas of expertise, whether any financial or intellectual interest was declared, the specific disclosures for Luz Maria De-Regil (Micronutrient Initiative affiliation), Gillian Gyte (NCT consultancy fees), Lynnette Neufeld (GAIN employment), and Lisa Noguchi (Gates Foundation/USAID grant to Jhpiego for group ANC research), and how each potential conflict was managed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-eng/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Annex 4:\tImplementation considerations for ANC guideline recommendations",
      "pageStart": 163,
      "pageEnd": 172,
      "target": "../sections/sec-016-annex-4-implementation-considerations-for-anc-gu.md",
      "narrative": null,
      "content": "Implementation considerations for ANC guideline recommendations\nNeed to know\nNeed to do\nNeed to have\nConsider\nA. Nutritional interventions\nA.1.1. Nutritional counselling on a \nhealthy diet and physical activity \n•\t Healthy diet and exercise in \nlocal context \n•\t Prevalence of overweight\n•\t Counselling\n•\t Counselling skills\n•\t Time and space for counselling \n•\t Gender issues and cultural \nexpectations of women\n•\t Local food security\nA.1.2. Nutritional education \non increasing daily energy and \nprotein intake \n•\t If your setting has an \nundernourished population\n•\t How to do counselling\n•\t Couns",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 4 presenting a comprehensive multi-page implementation matrix ('Need to know', 'Need to do', 'Need to have', and 'Consider') for each recommended and context-specific intervention across categories A (Nutritional interventions A.1.1–A.4, A.10), B (Maternal and fetal assessment B.1.1–B.2.5), C (Preventive measures C.1–C.7), D (Common physiological symptoms D.1–D.6), and E (Health systems interventions E.1–E.7), detailing health-system, facility, and provider requirements for commodities, training, counselling, task shifting, and quality assurance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    }
  ]
}
